Deep in the Amazon rainforest grows a small purple-red fruit called camu-camu. For many years, people in South America have valued this berry for its strong nutritional benefits. It is famous for containing extremely high levels of vitamin C, far more than oranges or lemons.
Scientists have also known that the fruit contains powerful plant chemicals that may protect the body from disease. Now researchers believe this tiny berry could play an unexpected role in helping doctors treat cancer.
A team of scientists from Université de Montréal has discovered that one natural compound inside camu-camu may help improve the effectiveness of a modern cancer treatment called immunotherapy.
Their research suggests that this compound could help the immune system fight cancer more strongly. The study was published in the scientific journal Cancer Discovery.
The compound that caught the scientists’ attention is called castalagin. It belongs to a group of plant chemicals known as polyphenols. Polyphenols are found in many fruits, vegetables, tea, and other plant foods.
These natural substances often act as antioxidants, meaning they help protect the body’s cells from damage. They can also reduce inflammation in the body, which is linked to many diseases.
Castalagin appears to have a special ability that makes it particularly interesting for cancer research. The compound can support the growth of helpful bacteria in the gut. These bacteria form part of what scientists call the gut microbiome.
The gut microbiome is a complex community of tiny organisms that live inside the digestive system. Over the past decade, researchers have discovered that these microbes play an important role in overall health, including digestion, immunity, and even mental well-being.
Scientists have also learned that the gut microbiome can influence how well cancer treatments work. Some patients respond very well to immunotherapy, while others see little benefit. Researchers have found that differences in gut bacteria may be one of the reasons for this variation.
Immunotherapy is a relatively new approach to cancer treatment that has changed the outlook for many patients. Unlike traditional treatments such as chemotherapy or radiation, immunotherapy works by helping the body’s own immune system recognize and attack cancer cells.
One type of immunotherapy, called immune checkpoint inhibitors, has shown remarkable success in certain cancers.
These drugs remove barriers that normally prevent the immune system from attacking tumors. When the barriers are removed, immune cells can find and destroy cancer cells more easily.
For some patients, this treatment can dramatically shrink tumors and extend survival. However, only a portion of patients respond well to this therapy. Many others see little or no improvement.
Because of this challenge, scientists around the world have been searching for ways to make immunotherapy work better for more people. The new research on camu-camu offers a possible solution.
In laboratory experiments using mice with cancer, the researchers gave castalagin orally. They observed that the compound changed the gut microbiome in a way that supported stronger immune activity against tumors. Certain helpful bacteria became more common in the gut, and this appeared to boost the immune system’s ability to attack cancer cells.
When castalagin was combined with immune checkpoint inhibitor therapy, the treatment worked better than immunotherapy alone. The mice showed a stronger anti-cancer response, suggesting that the natural compound helped the immune system become more effective.
Encouraged by these results, the researchers are now preparing to test castalagin in human patients. A clinical trial is expected to involve about 45 people who have either lung cancer or melanoma. These cancers are known to sometimes respond poorly to immunotherapy, so improving treatment effectiveness could make a major difference.
If the trial shows positive results, castalagin could become a valuable companion treatment used alongside existing cancer therapies. Instead of replacing immunotherapy, it would support it by improving the body’s immune response.
The discovery also highlights the growing interest in how natural compounds and nutrition may influence medical treatments. Many scientists now believe that diet, gut bacteria, and plant-based molecules could play an important role in supporting modern therapies.
Camu-camu has long been recognized as a healthy fruit, but this new research suggests its benefits may go far beyond basic nutrition. While it is still too early to say whether the berry itself will become a medical treatment, the compound found within it could help guide the development of new therapies.
By studying natural substances like castalagin, scientists are exploring how nature and modern medicine can work together. If future studies confirm these early findings, a small berry from the Amazon rainforest could help improve cancer treatment for patients around the world.
If you care about cancer, please read studies that low-carb diet could increase overall cancer risk, and new way to increase the longevity of cancer survivors.
For more health information, please see recent studies about how to fight cancer with these anti-cancer superfoods, and results showing daily vitamin D3 supplementation may reduce cancer death risk.
Copyright © 2026 Knowridge Science Report. All rights reserved.
